COMMONWEALTH OF AUSTRALIA

Instrument number PB 30 of 2011

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment April 2011 - Specification Under Subsection 84AAA(2)

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 25 March 2011

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

Amendment determination — Pharmaceutical Benefits - Early Supply

1 Name of Instrument

(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment April 2011 - specification under subsection 84AAA(2).

(2)           This Instrument may also be cited as No. PB 30 of 2011.

2 Commencement

This Instrument commences on 1 April 2011.

3 Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.

Schedule 1 Amendments

[1]                                   Schedule 1, after item dealing with Dipyridamole with aspirin

insert in the columns in the order indicated:

[2]                                   Schedule 1, item dealing with Amlodipine with valsartan

insert in the columns in the order indicated:

[3]                                   Schedule 1, item dealing with Mesalazine, Sachet containing prolonged release granules, 1 g per sachet

omit from the column headed “Maximum quantity or number of units”:

100

and substitute:

120